Macula Disease
MACULAR PUCKER
MACULAR HOLE
CELLOPHANE MACULOPATHY
DIABETIC TRACTION MACULOPATHY
VITREOMACULAR TRACTION SYNDROME
All are forms of traction maculopathy
Introduction
The vast
majority of operations on the macula are performed to relieve traction on
its surface (Figures 1). Such traction is usually the result of
spontaneous aging changes or diabetic scarring. This surgery is
common, highly successful, and has been available for more than
twenty years, with significant improvement in the 1990's.
Less frequently,
macular surgery is performed to treat aged related macular
degeneration - a term commonly used to describe degenerative
changes in the pigment and blood vessels beneath the macula. This
surgery removes blood or abnormal blood vessels beneath the macula,
or attempts to rotate the macula to overlie a healthier blood vessel
layer. This surgery is relatively recent, is less successful, and
is associated with greater risk.
Please see the Resources section for more information
on the surgical treatment of age-related macular degeneration. Discussion
is here confined to the surgical treatment of the various traction
maculopathies affecting the macular surface. You may review
the glossary of terms before proceeding,
or consult the glossary as necessary during your reading.
"Aging" Traction Maculopathy
About
6% of persons over the age of 50 gradually accumulate some detectable
scar tissue on the surface of the center of vision (the macula)
(Figure 2). This tissue, appearing as a subtle "cobweb",
is attached to the previously smooth and glistening macular surface
(the internal limiting membrane, or ILM)
As cells float
down to the macula from the vitreous cavity over a period of years, they attach to the ILM and then produce
a substance called collagen that links them together in a "membrane"
structure called epimacular proliferation (EMP). Cells reproduce (proliferate) and pull on the collagen, causing
the ILM to wrinkle (Figure 2). This wrinkles or distorts images
seen by the macula. Once the ILM is wrinkled, like crushed cellophane
wrap, it will probably never be entirely smooth again (cellophane
maculopathy).
Severe contraction
of EMP may wrinkle most of the thickness of the macula causing macular
pucker. Additionally, even modest proliferation on the ILM may
expand a small defect in the fovea to
produce a macular hole.
All this takes
place in an area about one millimeter in size! That's the size of
the center of vision. These changes involve both eyes in 10-30%
of cases, and can even reduce visual acuity to the level of 20/200
or legal blindness.
Diabetic
Traction Maculopathy
Diabetic
macular disorders require surgery when traction forces applied to
the macular surface by abnormal scar tissue are causing significant
structural and/or functional changes. This usually takes the form
of macular distortion or wrinkling, or even macular detachment,
in proliferative diabetic retinopathy. Recently, credible investigators
have shown substantial improvement of diffuse macular edema in non-proliferative
(background) diabetic retinopathy with surgical release of even
modest traction. This traction may be in the form of proliferation
on the ILM (cellophane maculopathy) causing tangential forces, or
anterior posterior (AP) forces caused by the pulling of the attached
vitreous gel (VMTS).
Vitrectomy
Surgery*
To
reach the macula, the surgeon typically performs vitrectomy surgery. Using a light pipe, a clear fluid infusion line, and a
vitreous cutter/aspirator, all about the size of a ball point pen
refill, the vitreous is removed using microscopic visualization.
The eye is kept inflated by liquid. Special care is taken to gently
remove the clear vitreous that may remain attached to the macula
(the cortical vitreous). Assuming no allergies to iodine, indocyanine
green (ICG) dye is then typically instilled to colorize the macular
surface ILM so as to substantially aid in subsequent dissection.
EMP is then
removed with delicate forceps if a distinct
EMP membrane is present (Figure 4). ICG dye can be re-injected to
more fully demonstrate the distorted underlying ILM, and this layer
may also be removed for complete traction release. It may also be
possible to remove the EMP/ILM complex in a single sheet.
In macular hole
surgery, EMP is usually subtle, requiring ILM removal for complete
traction release. This promotes the best possible hole closure rate,
and hole closure to the point of invisible edges post-operatively,
in our opinion (Reference 1).
Diabetic scar
tissue is first removed with a vitreous cutter and scissors until
the remaining surface traction is minimized. The surgery then proceeds
as discussed above.
*Developed
by Dr. Robert Machemer in 1971
References:
1. "Internal limiting membrane removal in the management of
full-thickness macular holes". Mester, V., Kuhn, F., American
Journal of Ophthalmology 129: 769-777, 2000
2. "Retinal Folds and Hemorrhagic Macular Cysts in Terson's
Syndrome," Morris, R., Kuhn, F., Witherspoon ,C.D. Ophthalmology
101:1, 1994.